Please login to the form below

Not currently logged in
Email:
Password:

SMC

This page shows the latest SMC news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

The SMC has approved its use on the NHS as a first-line treatment for people with advanced renal cell carcinoma (RCC), which could enable around 165 eligible patients in a

Latest news

More from news
Approximately 14 fully matching, plus 78 partially matching documents found.

Latest Intelligence

  • Patient involvement in health technology assessment Patient involvement in health technology assessment

    We have developed a Public Involvement Network (PIN) that formalises relationships with each submitting patient group through a registration process to become an SMC Patient Group Partner. ... SMC as a respected partner in developing and shaping all

  • The reality of real-world evidence The reality of real-world evidence

    Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

  • Charting a course for expansion Charting a course for expansion

    The dossiers are going in and the conversations with NICE and the SMC are happening and we're cautiously optimistic.”.

  • Sustainable solutions Sustainable solutions

    This is often most notable when Scotland's SMC takes a different opinion on a new drug from its counterpart for England and Wales, NICE. ... Looking at rulings in the decade to 2010 it found that NICE and the SMC held the same view on the availability of

  • Case study: Treatment guidance Case study: Treatment guidance

    Although NICE and the SMC had given positive opinions, UK experience of mifamurtide was limited.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics